SCHEMBL4034245

SCHEMBL4034245

CN(CCO)CCOc1cc(OC2CCCC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 18/20 0.67
SRC P12931 2/20 0.47
KDR P35968 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4035819 0.93 EGFR (0.78) EGFRSRCKDR
SCHEMBL4045999 0.93 EGFR (0.75) EGFRSRC
SCHEMBL4040826 0.91 EGFR (0.72) EGFRSRCKDR
SCHEMBL4037351 0.90 EGFR (0.74) EGFR
SCHEMBL4040120 0.89 EGFR (0.74) EGFRSRCKDR
SCHEMBL4210837 0.89 EGFR (0.77) EGFRSRCKDR
SCHEMBL4031397 0.88 EGFR (0.73) EGFRSRCKDR
SCHEMBL4037419 0.87 EGFR (0.77) EGFRSRCKDR
SCHEMBL4035880 0.87 EGFR (0.75) EGFRSRC
SCHEMBL4034607 0.87 EGFR (0.85) EGFRSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444211-B1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2009-01-21 EP disclosed